SCHEMBL1003791

SCHEMBL1003791

O=C(O)c1cc2c([nH]1)CCC2Cc1cccc(-c2ccc[nH]2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.36
ESR2 Q92731 4/20 0.36
BACE1 P56817 1/20 0.33
CNR1 P21554 1/20 0.33
ABL1 P00519 1/20 0.32
CDK2 P24941 1/20 0.31
GSK3A P49840 1/20 0.31
GSK3B P49841 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
MMP1 P03956 2/20 0.31
MMP2 P08253 2/20 0.31
MMP12 P39900 2/20 0.31
FFAR1 O14842 1/20 0.31
DDB1 Q16531 1/20 0.30
CRBN Q96SW2 1/20 0.30
HCAR2 Q8TDS4 1/20 0.30
MMP9 P14780 1/20 0.30
MCHR1 Q99705 1/20 0.30
DHODH Q02127 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2075046 0.88 ESR1 (0.33) ESR1ESR2BACE1CNR1ABL1
SCHEMBL2077165 0.87 MMP1 (0.41) ESR1ESR2MMP1MMP2MMP12
SCHEMBL1004854 0.83 ESR1 (0.44) ESR1ESR2MMP1MMP2MMP12
SCHEMBL1005137 0.82 ESR1 (0.42) ESR1ESR2MMP1MMP2MMP12
SCHEMBL1006707 0.82 ACMSD (0.39) ESR1ESR2ABL1MMP1MMP2
SCHEMBL12777445 0.82 DDB1 (0.44) ESR1ESR2DDB1CRBN
SCHEMBL1003853 0.82 DDB1 (0.44) ESR1ESR2DDB1CRBN
SCHEMBL1007274 0.80 KEAP1 (0.43) ESR1ESR2CDK2GSK3A
SCHEMBL2077375 0.80 KMO (0.43) GSK3BHDAC1
SCHEMBL1003672 0.80 HCAR2 (0.40) ESR1ESR2MMP1MMP2MMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
WO-2011011330-A2 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2011-01-27 WO disclosed
WO-2011011330-A2 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2011-01-27 WO disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE DDO, DAO, ACHE ESR1 3231/4885ESR2 4183/4885BACE1 28/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.